Yurong Gu

CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma

Yurong Gu, Xiangyong Li, Yanhua Bi et al. · Aging · 2020 · 130 citations · Full text

Medicine, Immunology, Oncology +17

Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma: a 10-year experience

Juan Liu, Huapeng Yu, Xicai Sun et al. · International Journal of Clinical Oncology · 2017 · 70 citations

Medicine, Otolaryngology, Surgery +15

CircPIAS1 promotes hepatocellular carcinoma progression by inhibiting ferroptosis via the miR-455-3p/NUPR1/FTH1 axis

Xiaoyu Zhang, Shanshan Li, Yurong Gu et al. · Molecular Cancer · 2024 · 65 citations · Full text

Medicine, Cancer Biology, Oncology +17

Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment

Lubiao Chen, Dujing Bao, Lin Gu et al. · BMC Infectious Diseases · 2018 · 60 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +12

<p>Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma</p>

Yanlin Huang, Gang Ning, Lubiao Chen et al. · Cancer Management and Research · 2019 · 58 citations · Full text

Medicine, Cancer Biology, Oncology +16